Oscar Howard Frazier

Oscar Howard Frazier's AcademicInfluence.com Rankings

Engineering

#5185

World Rank

#6429

Historical Rank

Biomedical Engineering

#372

World Rank

#381

Historical Rank

engineering Degrees

Oscar Howard Frazier

Philosophy

#7278

World Rank

#10469

Historical Rank

Logic

#4332

World Rank

#5610

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Oscar Howard Frazier's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Engineering Stanford University

Why Is Oscar Howard Frazier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Oscar Howard Frazier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Advanced heart failure treated with continuous-flow left ventricular assist device. (2009) (2748)
Use of a continuous-flow device in patients awaiting heart transplantation. (2007) (1631)
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. (2009) (837)
Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. (1992) (399)
Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group (2007) (377)
Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. (1999) (365)
Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long‐Term Implantable Left Ventricular Assist System (1995) (333)
Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. (2011) (326)
Sinus of Valsalva aneurysm or fistula: management and outcome. (1999) (317)
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. (2001) (310)
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. (1999) (299)
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. (2009) (298)
Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. (1997) (298)
Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. (2001) (290)
Left ventricular assist devices as destination therapy: a new look at survival. (2005) (285)
Primary cardiac sarcomas. (1991) (244)
Surgical treatment of cardiac tumors: a 25-year experience. (1990) (244)
Myocardial revascularization with laser. Preliminary findings. (1995) (231)
Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. (1996) (230)
Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. (2014) (201)
Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. (1994) (180)
The use of pyloric exclusion in the management of severe duodenal injuries. (1977) (177)
Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. (2011) (175)
Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989) (171)
Initial experience with the AbioCor implantable replacement heart system. (2004) (168)
The effect of coronary bypass on the outcome of peripheral vascular operations in 1093 patients. (1986) (165)
Resection of aortic arch aneurysms: a comparison of hypothermic techniques in 60 patients. (1983) (148)
TOTAL SUPPORT OF THE CIRCULATION OF A PATIENT WITH POST-CARDIOTOMY STONE-HEART SYNDROME BY A PARTIAL ARTIFICIAL HEART (ALVAD) FOR 5 DAYS FOLLOWED BY HEART AND KIDNEY TRANSPLANTATION (1978) (147)
Mechanical circulatory support and cardiac transplantation. (1998) (145)
Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. (1996) (135)
Surgical treatment of aneurysms of the transverse aortic arch: experience with 25 patients using hypothermic techniques. (1981) (134)
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. (1994) (134)
Early and late results of coronary endarterectomy. Analysis of 3,369 patients. (1986) (133)
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations. (1992) (130)
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. (1984) (126)
Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. (1990) (125)
The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. (1992) (124)
Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. (2010) (118)
Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. (2013) (114)
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. (1984) (106)
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. (1991) (103)
Laser-assisted microvascular anastomoses: angiographic and anatomopathologic studies on growing microvascular anastomoses: preliminary report. (1985) (96)
Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients. (1985) (95)
Hypothermic regional perfusion for protection of the spinal cord during periods of ischemia. (1987) (94)
The AbioCor implantable replacement heart. (2003) (90)
The effect of LVAD aortic outflow-graft placement on hemodynamics and flow: Implantation technique and computer flow modeling. (2005) (88)
Sustained Angina Relief 5 Years After Transmyocardial Laser Revascularization With a CO2 Laser (2001) (83)
Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. (1999) (83)
Congenital diverticulum of the ventricle. (1986) (81)
Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. (1993) (81)
Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices. (2015) (80)
Device-supported myocardial revascularization: safe help for sick hearts. (1992) (78)
Human cardiac explantation and autotransplantation: application in a patient with a large cardiac pheochromocytoma. (1985) (77)
Is an integrated approach warranted for concomitant carotid and coronary artery disease? (1997) (77)
Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. (1985) (76)
Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). (2013) (74)
Comparative evaluation of urographic contrast media, inulin, and 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation. (1989) (74)
Sinus venosus atrial septal defect: early and late results following closure in 109 patients. (1978) (73)
Circulatory Support for Long-Term Treatment of Heart Failure: Experience With an Intraventricular Continuous Flow Pump (2002) (71)
Parenteral Nutrition in Esophageal Cancer Patients (1982) (70)
Jarvik 2000 heart: potential for bridge to myocyte recovery. (1998) (70)
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. (1990) (68)
Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. (2005) (67)
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. (1999) (66)
Traumatic aortic transections: eight-year experience with the "clamp-sew" technique. (1997) (66)
Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. (1997) (66)
Factors predicting 10-year survival after heart transplantation. (2005) (66)
Total artificial heart in two-staged cardiac transplantation. (1981) (66)
Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. (2012) (65)
Complications in cardiac transplant patients requiring general surgery. (1988) (63)
Mechanical reliability of the Jarvik 2000 Heart. (2006) (63)
The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. (2000) (63)
EXACERBATION OF CYCLOSPORINE TOXICITY BY CONCOMITANT ADMINISTRATION OF ERYTHROMYCIN (1987) (62)
Low Serum Cholesterol Levels Predict High Perioperative Mortality in Patients Supported by a Left-Ventricular Assist System (1998) (61)
Implant technique for the Jarvik 2000 Heart. (2002) (60)
Intracavitary repair of ventricular aneurysm and regional dyskinesia. (1992) (60)
Resection of the Aortic Arch Using Deep Hypothermia and Temporary Circulatory Arrest (1978) (60)
Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. (2005) (59)
Cardiac transplantation in patients over 60 years of age. (1988) (59)
A system for grading cardiac allograft rejection. (1986) (58)
Improved multiorgan function after prolonged univentricular support. (1993) (57)
Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia (2016) (57)
Successful bridge to heart transplantation with a new left ventricular assist device. (1992) (56)
Over two decades of pediatric heart transplantation: how has survival changed? (2007) (56)
The antagonistic effect of rifampin upon cyclosporine bioavailability. (1984) (56)
The role of preoperative mesenteric arteriography in colon interposition. (1977) (53)
Intracorporeal (abdominal) left ventricular assist devices or partial artificial hearts: A five-year clinical experience. (1981) (53)
The role of surgery following chemotherapy in stage III germ cell neoplasms. (1983) (53)
In vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta. (2006) (52)
Postauricular percutaneous power delivery for permanent mechanical circulatory support. (2002) (52)
Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery. (1997) (51)
Circulatory support with attenuated pulse pressure alters human aortic wall morphology. (2007) (51)
Initial experience with the Jarvik 2000 left ventricular assist system as a bridge to transplantation: report of 4 cases. (2001) (51)
A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. (2001) (51)
Durability and low thrombogenicity of the St. Jude Medical valve at 5-year follow-up. (1986) (51)
Destination therapy with a rotary blood pump and novel power delivery. (2009) (51)
Mechanical Circulatory Support for Advanced Heart Failure: Where Does It Stand in 2003? (2003) (50)
Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. (2013) (49)
Heart transplantation after mechanical circulatory support: four years' experience. (1992) (48)
Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. (2014) (48)
Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. (1991) (48)
Brachiocephalic reconstruction I: operative and long-term results for complex disease. (2005) (48)
Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. (1994) (47)
Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. (1994) (47)
Brachiocephalic reconstruction II: operative and endovascular management of single-vessel disease. (2005) (47)
THE RELATIONSHIP AMONG DONOR‐RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1 (1994) (46)
High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII. (2009) (46)
Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland. (2001) (45)
The past 50 years of cardiovascular surgery. (2000) (45)
Long-term results in diabetic patients undergoing heart transplantation. (1992) (45)
Early experience with the ionescu-shiley pericardial xenograft valve. Accelerated calcification in children. (1983) (45)
Leishmaniasis in a heart transplant patient. (1992) (45)
MITRAL LEAFLET PROLAPSE: SURGICAL TREATMENT USING A POSTERIOR ANNULAR COLLAR PROSTHESIS. (1976) (44)
The older cardiac transplant donor. Relation to graft function and recipient survival longer than 6 years. (1989) (44)
Development of an implantable ventricular assist system. (1997) (43)
Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients. (1991) (43)
Use of potentially infected donor hearts for cardiac transplantation. (1990) (43)
The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. (1998) (43)
Surgical management of patients in the REMATCH trial. (2003) (42)
Transmyocardial laser revascularization in the patient with unmanageable unstable angina. (1999) (42)
Bacterial mediastinitis after heart transplantation. (1992) (42)
Use of Ventricular Assist Devices and Heart Transplantation for Advanced Heart Failure. (2019) (41)
Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. (2006) (41)
Heterotopic heart transplantation: a reliable option for a select group of high-risk patients. (1989) (41)
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. (1991) (40)
The effects of pulsatile versus nonpulsatile perfusion on blood viscoelasticity before and after deep hypothermic circulatory arrest in a neonatal piglet model. (1999) (40)
A model to predict survival at time of postcardiotomy intraaortic balloon pump insertion. (1993) (40)
Revascularization procedures in patients with transplant coronary artery disease. (1997) (39)
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. (1999) (39)
Neurologic complications of heart transplantation in children. (1992) (38)
Six years of continuous mechanical circulatory support. (2006) (37)
Neurohormonal Changes After Implantation of a Left Ventricular Assist System (1998) (37)
Building a Total Bioartificial Heart: Harnessing Nature to Overcome the Current Hurdles (2018) (36)
Thirty-five years of mechanical circulatory support at the Texas Heart Institute: an updated overview. (2005) (36)
Clinical experience with the Hemopump. (1989) (36)
Long‐Term Mechanical Circulatory Support System Reliability Recommendation American Society for Artificial Internal Organs and Society of Thoracic Surgeons: Long‐Term Mechanical Circulatory Support System Reliability Recommendation (1998) (34)
Concomitant brachiocephalic and coronary artery disease: outcome and decision analysis. (2005) (34)
Salvage of Infected Left Ventricular Assist Device with Antibiotic Beads (2014) (34)
Transmyocardial laser revascularization. (1996) (34)
Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. (2005) (32)
Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation (2016) (32)
The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation. (1996) (32)
Effect of prior cardiac surgery on survival after heart transplantation. (1989) (31)
Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine. (1986) (30)
Total left ventricular outflow tract obstruction due to left ventricular assist device-induced sub-aortic thrombosis in 2 patients with aortic valve bioprosthesis. (2003) (30)
Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. (2004) (29)
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. (2001) (29)
Concomitant cardiac and pulmonary operations for lung cancer. (1995) (29)
Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up. (2005) (29)
Implantation techniques for the Hemopump. (1989) (28)
Transmyocardial laser revascularization in allograft coronary artery disease. (1998) (28)
Bridging to a Long‐Term Ventricular Assist Device With Short‐Term Mechanical Circulatory Support (2018) (28)
The Jarvik 2000 Heart. Clinical validation of the intraventricular position. (2002) (28)
THE IMPACT OF HLA A, B, AND DR BLOOD TRANSFUSIONS AND IMMUNE RESPONDER STATUS ON CARDIAC ALLOGRAFT RECIPIENTS TREATED WITH CYCLOSPORINE (1988) (27)
Coronary artery bypass two years after orthotopic heart transplantation: a case report. (1991) (27)
Mechanical circulatory support in children. (1994) (27)
Mechanical cardiac assistance: historical perspectives. (2000) (27)
Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique. (2002) (26)
Overseas transport of a patient with an extracorporeal left ventricular assist device. (1995) (26)
Postpericardiotomy syndrome in pediatric heart transplant recipients. Immunologic characteristics. (1995) (25)
Regional extension of lung cancer. (1980) (25)
Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. (2005) (24)
Mechanical circulatory support : the Bad Oeynhausen experience. Discussion (1995) (24)
Heart transplantation in Jehovah's Witnesses. An initial experience and follow-up. (1990) (24)
Clinical applications of the supraceliac aorta: anatomical and pathologic observations. (1987) (24)
Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation. (1994) (23)
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. (2005) (23)
Total artificial heart (TAH) utilization in man. (1982) (23)
Implantation technique for the HeartMate left ventricular assist device. (1992) (23)
Guillain-Barré syndrome after heart transplantation. (1992) (22)
Nonthrombogenic, adhesive cellular lining for left ventricular assist devices. (1998) (22)
Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. (1986) (21)
Ventricular assist device placement in an adult with D-transposition of the great arteries with prior Mustard operation. (2010) (21)
Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients. (2004) (21)
Coronary artery revascularization without cardiopulmonary bypass. (1984) (20)
Assessment of myocardial recovery using dobutamine stress echocardiography in LVAD patients. (2001) (20)
Inverse relationship between human leukocyte antigen match and development of coronary artery disease. (1991) (20)
Cutaneous T-cell lymphoma in a cardiac transplant recipient. (2001) (20)
Pleural and pericardial effusions in cancer patients. (1985) (20)
Antifibrinolytic therapy in cardiac surgery. (1995) (20)
Usefulness of the QTc interval in predicting acute allograft rejection. (1998) (20)
Fatal disseminated adenoviral infection in an adult heart transplant patient. (2004) (19)
Fatal Cardiac and Renal Allograft Rejection With Lenalidomide Therapy for Light‐Chain Amyloidosis (2013) (18)
Outpatient LVAD: its time has arrived. (1994) (18)
Nephrotoxicity of cyclosporine. (1985) (18)
Cyclosporine A pharmacokinetics in a cardiac allograft recipient with a jejuno-ileal bypass. (1988) (18)
Surgical treatment of mitral systolic click syndrome: results in 37 patients. (1985) (17)
Treatment of cardiac allograft failure by use of an intraaortic axial flow pump. (1990) (17)
Long-term biventricular support with rotary blood pumps: prospects and pitfalls. (2012) (17)
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. (2005) (17)
Induction of hyperthermia using implanted electrodes. (1984) (17)
The St. Jude medical valve: early clinical results in 253 patients. (1983) (16)
Cardiac Improvement During Mechanical Circulatory Support (2007) (16)
Effect of ABO blood type on survival of heart transplant patients treated with cyclosporine. (1989) (16)
Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients. (1998) (16)
Long-term results of direct vertebral artery operations. (1984) (16)
Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease? (1998) (16)
Mechanical circulatory support: new advances, new pumps, new ideas. (2002) (16)
The development of an implantable, portable, electrically powered left ventricular assist device. (1994) (15)
Nutritional assessment of patients with extended left ventricular assist device support. (1990) (15)
Left atrial metastasis from hepatocellular carcinoma: a case report. (1994) (15)
Reducing mortality in patients with extensive myocardial infarction. (1991) (15)
3 Combination Therapy with Pulsatile Left Ventricular Assist Device, Heart Failure Medication and Clenbuterol in Chronic Heart Failure: Results from HARPS (2011) (15)
Histologic findings proving the existence of humoral rejection in a cardiac allograft. (2007) (14)
Cardiac transplantation for pediatric patients. With inoperable congenital heart disease. (1998) (14)
Extracorporeal membrane oxygenation: its role in the survival of a child with adenoviral pneumonia and myocarditis. (1983) (14)
Anastomosis of bypass grafts using a low‐powered CO2 laser (1989) (14)
Cardiac transplantation at the Texas Heart Institute: comparative analysis of two groups of patients (1968-1969 and 1982-1983). (1985) (14)
Patients Awaiting Heart Transplantation on HVAD Support for Greater Than 2 Years (2016) (14)
Cardiac transplantation in a Jehovah's witness. (1988) (14)
Why referred potential heart donors aren't used. (1993) (14)
Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. (2017) (13)
Left ventricular assist device as a bridge to partial left ventriculectomy. (1999) (13)
Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy. (1989) (13)
Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. (1998) (13)
Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. (1998) (13)
Optimism derived from 7.5 years of continuous-flow circulatory support. (2010) (13)
Rapamycin reduces rejection in heart transplant recipients. (2001) (13)
Cardiac transplantation in a patient with septicemia after prolonged intraaortic balloon pump support: implications for staged transplantation. (1986) (12)
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. (2019) (12)
Future directions of cardiac assistance. (2000) (12)
Effects of systemic hyperthermia and intrahepatic infusion with 5‐fluorouracil (1982) (12)
Reevaluation of steroid tapering after steroid pulse therapy for heart rejection. (1992) (12)
Nutritional management of the heart transplant recipient. (1985) (12)
Mechanical Circulatory Support for Advanced Heart Failure (2018) (11)
Improved survival after Hemopump insertion in patients experiencing postcardiotomy cardiogenic shock during cardiopulmonary bypass. (1990) (11)
Case 5 Familial Right Ventricular Dysplasia (Cardiomyopathy) (1995) (11)
Transmyocardial laser revascularization: histopathological findings. (1998) (11)
Ionescu-Shiley Bovine Pericardial Bioprostheses (1985) (11)
Cellular linings of ventricular assist devices. (1995) (11)
True aneurysm of the saphenous vein graft stump associated with CABG in a cardiac transplant patient. (1992) (11)
HeartMate vented-electric left ventricular assist system: technique for intrathoracic or intraperitoneal implantation via a left thoracotomy. (2004) (10)
Cardiac transplantation with the use of cyclosporin a for immunologic suppression. (1982) (10)
Safe, effective off-pump sternal sparing approach for HeartMate II exchange. (2013) (10)
Heterotopic heart transplantation in three patients at the Texas Heart Institute. (1985) (10)
Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody. (1997) (10)
Laser-assisted anastomosis of large-diameter vessels with the carbon dioxide laser. (1988) (10)
The treatment of advanced cardiac allograft rejection. (1988) (10)
Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices (2018) (10)
In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study (2018) (10)
Partial Left Ventriculectomy and Limited Heart Transplantation Availability (2001) (9)
Previous challenges and current progress–the use of total artificial hearts in patients with end-stage heart failure (2016) (9)
Preclinical hemodynamic assessment of a new trileaflet mechanical valve in the aortic position in a bovine model. (2004) (9)
Peripheral organ perfusion augmentation during left ventricular failure. A controlled bovine comparison between the intraaortic balloon pump and the Hemopump. (1993) (9)
The surgical treatment of aortopulmonary window. (1983) (9)
Heterotopic heart-single lung transplantation: report of a new technique. (1987) (9)
An ex vivo model for the reperfusion of explanted human hearts. (1993) (9)
Postcardiotomy LVAD support and transesophageal echocardiography in a child. (1993) (9)
Early and late results of coronary endarterectomy in 3,369 patients. (1988) (9)
Recovery of pulmonary function in patients undergoing extended left ventricular assistance. (1992) (9)
Use of Remote Pulmonary Artery Pressure Monitoring (CardioMEMS System) in Total Artificial Heart to Assess Pulmonary Hemodynamics for Heart Transplantation. (2017) (9)
Occlusive coronary arteritis: a cause of early death in a cardiac transplant patient. (1987) (9)
Mechanical circulatory assist device development at the Texas Heart Institute: a personal perspective. (2014) (9)
Resurrection after mechanical circulatory support. (1997) (8)
Nonpulsatile total left ventricular support in pediatric patients (1992) (8)
First Implantation of a Novel Left Ventricular Assist Device: The ReliantHeart aVAD. (2017) (8)
Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. (2015) (8)
Treating cardiac allograft rejection: present approach--analysis of 100 consecutive patients. (1990) (8)
Systemic thermochemotherapy: toxicity and plasma pharmacokinetics of methotrexate and doxorubicin. (1984) (8)
Total artificial heart implantation as a bridge to transplantation: a viable model for the future? (2018) (8)
Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. (2019) (7)
Aortic valve implantation in the calf: a successful approach using Heartport cannulation and minimally invasive techniques. (2001) (7)
Internal pulsatile circulatory support. (1993) (7)
237 HVAD BTT Pivotal Trial and Continued Access Program (ADVANCE): Interim Report of the Expanded Study (2011) (7)
Trauma in patients with continuous-flow left ventricular assist devices. (2013) (7)
Epicardial cryoablation of the bundle of His. An experimental study. (1984) (7)
Successful treatment of invasive aspergillosis in a heart transplant patient. (1985) (7)
Progress in cardiac transplantation. (1994) (7)
Total artificial heart implantation for biventricular failure due to eosinophilic myocarditis (2017) (7)
Treatment of moderate heart allograft rejection with cyclosporine. (1986) (7)
Modification of a Volume-Overload Heart Failure Model to Track Myocardial Remodeling and Device-Related Reverse Remodeling (2011) (7)
Infection after cardiac transplantation: treatment and prognosis. (1984) (7)
Quality of life in long-term survivors of the Hemopump left ventricular assist device. (1991) (7)
Addition of papaverine to cardioplegia does not reduce myocardial necrosis. (1986) (7)
Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation. (1996) (7)
Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation. (1989) (6)
IMPROVED IMMUNOSUPPRESSION FOR HEART TRANSPLANT PATIENTS USING INTRAVENOUS DOSES OF CYCLOSPORINE (1989) (6)
Implantation of the HeartMate II in a Patient of 34 Years after a Mustard Procedure (2012) (6)
Repeated endomyocardial biopsy without complication in an infant after heart transplantation. (1986) (6)
Abstract 18067: Young Patients With Non-Ischemic Cardiomyopathy Have Higher Likelihood of Left Ventricular Recovery During HeartMate II Support: Data From the Bridge and Destination Therapy Trials (2010) (6)
Initial multicenter clinical results with the HeartMate® II axial flow left ventricular assist device (2005) (6)
Linked pacing after heterotopic heart transplantation with concurrent left ventricular reduction of the native heart. (1998) (6)
Management of patients supported on the Hemopump cardiac assist system. (1992) (6)
Michael E. DeBakey, 1908 to 2008. (2008) (6)
Outcomes in patients with low left ventricular ejection fraction after heart transplantation. (2003) (6)
Cardiopulmonary allotransplantation, a collective review: experimental progress and current clinical status. (1983) (6)
4: Patients with Mechanical Circulatory Support (MCSD): Is Implant Strategy Static or Dynamic? (2008) (6)
Quality of life of patients on LVAD support (1992) (6)
Myocardium-sparing cannulation technique for left ventricular assist device support. (1991) (6)
Stenting of the ductus arteriosus in hypoplastic left heart syndrome as an ambulatory bridge to cardiac transplantation. (1994) (6)
Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels (2018) (5)
Selective use of OKT3 in heart transplantation with the use of risk factor analysis. (1989) (5)
Low rate of cardiac recovery despite cellular recovery during LVAD support: results from the LVAD working group (2004) (5)
CORRECTION OF ANOMALOUS VENOUS RETURN FROM THE RIGHT LUNG TO THE INFERIOR VENA CAVA (SCIMITAR DEFORMITY). (1976) (5)
Outcomes of Repeat Left Ventricular Assist Device Exchange (2020) (5)
Portable Electric Systems for Long-Term Use (1993) (5)
Cardiac transplantation: current results at the Texas heart institute. (1984) (5)
Improved cardiac function following left ventricular aneurysm resection: pre- and postoperative performance studies in 150 patients. (1982) (5)
Familial right ventricular dysplasia (cardiomyopathy). (1995) (5)
Effect of IgM-positive crossmatches on survival in heart transplant recipients. (1995) (5)
Open chest resuscitation for cardiopulmonary arrest related to mechanical impairment of circulation: a report of two cases. (1982) (5)
Concomitant donor heart coronary artery bypass grafting during orthotopic heart transplantation. (1990) (5)
Heart transplantation: approaching a new century. (1999) (5)
Cardiac transplantation and mechanical circulatory assistance: the Texas Heart Institute experience. (1989) (4)
Rapid placement of the Hemopump and hemofiltration cannula. (1990) (4)
Circulatory support 1991. The Second International Conference on Circulatory Support Devices for Severe Cardiac Failure. Anticoagulation. (1993) (4)
Percutaneous transluminal coronary angioplasty after cardiac transplantation. (1989) (4)
Use of Cardiac Assist Devices as Bridges to Cardiac Transplantation: Review of Current Status and Report of the Texas Heart Institute’s Experience (1989) (4)
Off-pump coronary artery bypass grafting and transmyocardial laser revascularization via a left thoracotomy. (2003) (4)
345: Median Axial Flow Pump Speed Associated with Cessation of Aortic Valve Opening Is an Indicator of Remission of Chronic Heart Failure in Patients Supported by a Left Ventricular Assist Device (2008) (4)
Cardiac devices. (1996) (4)
Vascular trauma as a result of therapeutic procedures for the treatment of malignancy. (1991) (4)
Long-term follow-up of cyclosporine-treated cardiac transplant recipients. (1990) (4)
Right hydrothorax after left subclavian and internal jugular vein catheterization: a delayed complication. (1985) (4)
Early results of cardiac transplantation at the Texas Heart Institute. (1984) (4)
Variability of organ utilization criteria exacerbates the national shortage of heart donors (1991) (4)
Evolutionary perspective of mechanical circulatory support as a bridge to heart transplantation. (2017) (4)
Surgical technique and hemodynamic characteristics of partial cardiac replacement with an artificial left ventricle. (1986) (4)
The HeartMate: a left ventricular assist device as a bridge to cardiac transplantation. (1992) (4)
The State of Artificial Heart Therapy. (2019) (4)
Left ventricular reduction in a Jehovah's Witness. (2000) (4)
Acute pancreatitis complicating OKT3 administration for resistant cardiac rejection. (1993) (4)
Outcomes in patients who underwent a concomitant tricuspid valve procedure during left ventricular assist device implantation (2019) (4)
Novel Oral Anticoagulants in Patients with Continuous Flow Left Ventricular Assist Devices (2019) (4)
Increasing importance of adjuvant surgery in inoperable lung cancer. (1984) (3)
Semiquantitative histomorphometric analysis of myocardium following partial left ventriculectomy: 1‐year follow‐up (2004) (3)
Discussion of implantable nonpulsatile devices (2001) (3)
Cause and importance of donor neurogenic myocardial injury in cardiac transplantation. (1987) (3)
Preliminary results of intraoperative excimer laser angioplasty: Phase 1: An adjunct to coronary artery bypass surgery (1992) (3)
Mechanical circulatory assist device development at the Texas Heart Institute: a personal perspective. (2014) (3)
Cardiovascular Magnetic resonance imaging of sarcoma invading the left atrium and pericardium. (2005) (3)
Cardiac surgical emergencies. (1989) (3)
Preoperative and postoperative Hemopump support for patients undergoing orthotopic heart transplantation. (1992) (3)
Total artificial hearts and ventricular assist devices as bridges to heart transplantation. (1988) (3)
Surgical treatment of multiple coronary aneurysms in an elderly man. (1996) (3)
Evolution of renal function in cardiac vs. renal allograft recipients receiving long-term cyclosporine A (CsA) immunosuppressive therapy. (1989) (3)
Replacement of the left ventricle with a single-chambered artificial pump. (1986) (3)
LVAD treated heart recipients do not have deleterious HLA antibody. (2001) (3)
Mechanical Circulatory Support (2020) (3)
Transmyocardial laser revascularization as a new therapeutic option for refractory coronary artery occlusive disease. (1998) (3)
Malignant pleural mesothelioma with a 14‐year survival: A case report and electronmicroscopic study (1982) (3)
Orthotopic cardiac transplantation in patients with large donor/recipient atrial size mismatch: surgical technique. (1987) (3)
Intrapericardial pheochromocytoma. (1983) (3)
Experience with the ST. JUDE MEDICAL® Valve and the IONESCU-SHILEY® Bovine Pericardial Valve at the Texas Heart Institute (1985) (3)
Cardiac transplantation: indications, procurement, operation, and management. (1985) (3)
Numerical and Experimental Approach to Characterize a BLDC Motor with Different Radial-gap to Improve Hemocompatibility Performance (2020) (3)
Perioperative Use of Neseritide in Heart Failure Patients Undergoing Implantation of Left Ventricular Assist Device (2003) (3)
95: Clinical Experience with Recombinant Factor VII Use in Patients with Left Ventricular Assist Devices (2008) (2)
In Memoriam: Tetsuzo Akutsu 1922–2007 (2008) (2)
Sustained angina relief five years after transmyocardial revascularization with a CO2 laser (2001) (2)
Separation of the natural atria in experimental implantation of total artificial heart. (1995) (2)
Heterotopic Cardiac Transplantation: Long-term Results and Fate of the Native Heart. (2020) (2)
Cardiac transplantation at the Texas Heart Institute: recent experience. (1985) (2)
Implantable cardioverter defibrillator patch erosion in a heart transplant patient. (2001) (2)
Analysis of rejection in cyclosporine-treated cardiac allograft recipients. (1988) (2)
Bariatric Surgery in Patients with Continuous Flow Left Ventricular Assist Devices (2018) (2)
Cellular regression of fibrosis and hypertrophy following chronic LVAD support does not translate into sustained improvements in contractile function: results from the LVAD working group (2003) (2)
Adjuvant native heart surgery during heterotopic heart transplantation: two case reports. (1991) (2)
(498) – How Does the Pulse Pressure Impact on Cerebral Autoregulation Between Axial and Centrifugal LVAD? (2017) (2)
Plasmapharesis in Patients with Heparin-Induced Thrombocytopenia Requiring Ventricular Assist Device. (2019) (2)
The heart donor: special considerations. (1988) (2)
The Man with 2 Hearts: 25 Years from Heterotopic to Orthotopic Heart Transplantation. (2019) (2)
As originally published in 1988: Cardiac transplantation in patients over 60 years of age. Updated in 1997. (1997) (2)
Heart transplantation in an 8-month-old girl. 10th anniversary report. (1995) (2)
Legionella infections in cyclosporine-immunosuppressed cardiac transplants. (1985) (2)
P95: Adjustable gastric banding (AGB) in pre-transplant patients (2008) (2)
Left ventricular outflow tract closure during LVAD implantation: 2 cases of patients supported for over 6 years (2017) (2)
Combination chemotherapy for sarcomas with cyclophosphamide and continuous infusion adriamycin and dacarbazine (CICyADIC) with surgical intensification (1981) (2)
Investigational trials of the Hemopump at the Texas Heart Institute: practical issues (1991) (2)
251: Clinical relevance of crossmatch results, HLA and non-HLA Ab antibodies for cardiac allograft recipients (2007) (2)
Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site. (2019) (2)
Cardiac recovery during 30 days of support with a left ventricular assist device. Preliminary results from the LVAD working group (2003) (2)
P718 - PRA-STAT identifies high-risk, alloimune recipients (1996) (2)
689: Long-Term Survival after Left Ventricular Assist Device Explantation (2009) (2)
Evolution of the Texas Heart Institute Distant Organ Procurement Program. (1984) (2)
Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use (2015) (2)
62: Strategies for LVAD Therapy in INTERMACS: Intent Rate v. Event Rate (2010) (2)
178 Risk of Bleeding and Stroke in 700 HeartMate II LVAD Outpatients (2011) (2)
Use of magnetic resonance imaging to assess myocardial perfusion after transmyocardial laser revascularization. (2009) (2)
Impact of Tandem Heart Use for Heart Failure Patients as a Bridged to Long-term Continuous Flow Left Ventricular Assist Devices (2018) (1)
459: Positive Flow Cytometery Crossmatches and HLA Antibodies May Not Be Contraindications to Heart Transplantation (2010) (1)
(85) - Effect of Preoperative Atrial Fibrillation on Patients with Undergoing Implantation of Long-Term Continuous Flow Ventricular Assist Devices (2017) (1)
Impact of Body Mass Index on Implantation of a Continuous-Flow Left Ventricular Assist Device: Single-Center 508 Patient Experience (2017) (1)
The Jarvik 2000: Results of the United States Bridge to Transplant Trial (2016) (1)
Impact of Elevated Preoperative Blood Urea Nitrogen (BUN) Levels on Outcomes in CF-LVAD Patients (2019) (1)
Different Risk Factors for Ischemic and Hemorrhagic Stroke on Continuous Flow Left Ventricular Assist Device Support (2019) (1)
Cardiac rhabdomyoma in neonates. (1985) (1)
Abstract 18793: Patients Awaiting Heart Transplantation on HeartWare Ventricular Assist Device Support for Greater than Two Years (2014) (1)
Preocclusive Carotid Artery Thrombosis: Pathogenesis and Management (1999) (1)
Comparison of Sternotomy Versus a Subcostal Approach for Exchange of HeartMate II Continuous Flow-left Ventricular Assist Device (2018) (1)
Editorial Comment: Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness. (2015) (1)
Preocclusive thrombosis of an internal carotid artery. (1998) (1)
3 Implant Strategies for Continuous Flow LVAD Therapy in INTERMACS – Impact on Outcomes and Variability over Time (2012) (1)
Predictors of rejection in cyclosporine-treated cardiac allograft recipients. (1987) (1)
An abdominal left ventricular assist device (ALVAD): perspective and prospects. (2004) (1)
Outcomes of LVAD Implantation in Ischemic versus Nonischemic Cardiomyopathy (2019) (1)
784 Clinical Experience with Patients over Age 65 Who Undergo HeartMate II LVAD Placement for Destination Therapy (2012) (1)
An experimental technique for heart-lung transplantation in subprimate models. (1990) (1)
Antifibrinolysis and Blood-Saving Techniques (1)
Heart transplantation in 234 patients: review of the Texas Heart Institute six-year experience. (1989) (1)
Improvement of reversible ischemia in severe post-transplantation coronary artery disease. (1998) (1)
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. (2003) (1)
A 4-Chamber Model Heart with 3D Printed Silicone Aorta and Peripheral Arteries to Simulate the Human Cardiovascular System in a Mock Circulatory Loop (2019) (1)
143: Pump Replacement for LVAD Failure Can Be Done Safely and Is Associated with Low Mortality (2010) (1)
Is Pre-operative Dialysis a Contraindication to Continuous-flow Left Ventricular Assist Device (CF-LVAD) Implantation? (2018) (1)
856-2 Cardiac recovery during left ventricular assist device support: Results from the LVAD working group (2004) (1)
Gastrointestinal Bleeding Ceases after Heart Transplantation in Patients Bridged on Continuous-Flow LVAD Support (2019) (1)
(83) - Neurological Complications in Patients Supported with Continuous Flow Left Ventricular Assist Devices - Comparative Analysis of HeartMate II and HeartWare Devices (2017) (1)
Completely implantable total artificial hearts: Status at the Texas Heart Institute (1991) (1)
Recurrent malignant pleural mesothelioma: case report. (1983) (1)
Investigating a Novel Synergy Applying Remote I schemic Conditioning to M odulate the Altered P hysiology of Contin U ous Flow L eft Ventricular Assist Devices, to Reduce S troke and Other Adverse E ffects: The IMPULSE Trial Pilot Results (2016) (1)
Intravenous administration of cyclosporine for immunosuppression in heart transplant patients. (1989) (1)
1059-30 Effect of nesiritide on renal function after implantation of the abiocor total artificial heart (2004) (1)
EFFECTS OF PREEMPTIVE THERAPY IN HEART TRANSPLANT PATIENTS WITH CYTOMEGALOVIRUS - ANTIGENEMIA (1999) (1)
513: One Year Followup with a Continuous Flow LVAD as a Bridge to Heart Transplantation (2008) (1)
Treatment of coronary artery stenosis by laser technique (1985) (1)
Transmyocardial laser revascularization [1] (multiple letters) (2000) (1)
LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IN A PATIENT WITH LONG-TERM NON-PROGRESSIVE HUMAN IMMUNODEFICIENCY VIRUS (2019) (1)
Hemodynamic Improvement with Application of Mechanical Circulatory Support in Heart Failure with Preserved Ejection Fraction in a Mock Circulation Loop (2019) (1)
Preoperative Risk Factors for Stroke After HeartWare Left Ventricular Assist Device Implantation: Texas Heart Institute Experience (2016) (0)
Hyperimmune IVIG may be advantageous in comparison to intravenous ganciclovir as a preemptive antiviral therapy in CMV-positive heart transplant recipients (2002) (0)
Preliminary findings using in vivo imaging with radiolabeled monoclonal antibody to ICAM-1 and MHC class II antigen in cardiac allograft rejection (1995) (0)
History of Mechanical Circulatory Support (2018) (0)
283: Use of the Tandem Heart Percutaneous Ventricular Assist System in High-Risk Cardiac Surgery (2008) (0)
Influence of gender on allograft rejection in cardiac transplantation (1990) (0)
Evaluation of the CHADS 2 , CHA 2 DS 2 -VASc, and R 2 CHADS 2 Risk Assessment Scores in Continuous Flow LVADs (2018) (0)
Cardiac recovery during support with a left ventricular assist device. Results from the LVAD working group (2003) (0)
227: Dual continuous flow pumps for total heart replacement (2006) (0)
Mortality From Neurological Complications While on Continuous-flow Left Ventricular Assist Device Support (2018) (0)
Transmyocardial Revascularization Using CO2 Lasers in Ischemic Heart Disease (2015) (0)
The relationship between donor-recipient HLA mismatches, rejection and death from coronary artery disease in cardiac transplant recipients (1992) (0)
346: Reversal of Secondary Pulmonary Hypertension in Patients Supported by Left Ventricular Assist Devices (2008) (0)
LVAD Surgical Implant Technique: Infradiaphragmatic Approach (2018) (0)
279: Axial vs Pulsatile Flow in Reversing Pulmonary Hypertension in Heart Failure Patients Supported by Left Ventricular Assist Devices (2009) (0)
Continuous-flow Left Ventricular Assist Device Therapy in Adult Patients With Congenital Heart Disease (2018) (0)
72 Multicenter clinical evaluation of the HeartMate II axial flow left ventricular assist device in patients with severe heart failure: hemodynamic effects, pump performance and quality of life (2006) (0)
11 Intermediate follow-up of pediatric heart transplant patients with elevated pulmonary vascular resistance (1993) (0)
Heart transplantation: a therapeutic alternative for patients with end-stage cardiac disease: the Texas Heart Institute experience. (1985) (0)
At Left Ventricular Assist Device (LVAD) Implantation, Morphologic Differences Are Observed Between Patients With Improved Cardiac Function Allowing LVAD Removal and Patients With Prolonged LVAD Support as a Bridge to Transplantation (2015) (0)
Weaning of Mechanical Cardiac Support Guided by Dobutamine Stress Testing (2008) (0)
Outcomes of Continuous Flow Left Ventricular Assist Devices: A Single Institutional 18-Year Experience with Over 850 Devices (2018) (0)
In Memoriam: Branislav Radovancevic 1952–2007 (2007) (0)
Long Term Survival Outcomes Following Heart Transplantation are Significantly Impacted by Recipient Smoking Status (2018) (0)
Myocardial Laser Revascularization (2006) (0)
(439) - Concomitant Valve Procedures Are Not Associated with Higher Perioperative Mortality (2017) (0)
Abstract TP211: Outcomes and Predictors of Postoperative Atrial Fibrillation in Patients With Left Ventricular Assist Devices (2019) (0)
Thal patch gastroesophagoplasty: chest radiographic findings simulating leak or abscess. (1988) (0)
Invited Lecture “Pioneering the Future: From Transplant to Device Development” (2017) (0)
Statins improve long-term survival and reduce incidence of hemodynamically significant rejection. (2001) (0)
The isolated supported human heart: A novel model for the study of new diagnostic and therapeutic modalities (1991) (0)
On the way to permanent support: Battery-powered, vented ventricular assist systems and other innovative new systems (1997) (0)
515: Predictors of Stroke on Heartmate II Left Ventricular Assist Device (2009) (0)
MECHANICAL CIRCULATORY ASSISTANCE HAVE WE REACHED THE END OF THE BEGINNING (2004) (0)
Abstract 2457: Left Ventricular Assist Device Therapy with the HeartMate II Continuous Flow Rotary Pump as a Bridge to Heart Transplantation (2007) (0)
Vascular thrombosis in patients with long term Jarvik 2000 VAD support (2003) (0)
Timing Of RVAD Insertion and The Associated Outcomes in CF-LVAD Patients (2018) (0)
First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use (2014) (0)
Abstract295: End-organ function in patients on long-term circulatory support with continuous or pulsatile blood flow assist devices (2006) (0)
INTERMACS Profile Does Not Predict Required Flow Rate of CF-LVAD at Discharge (2019) (0)
Low dose dobutamine echocardiography, thallium scintigraphy and 18-fluorodeoxglucose positron emission tomography for detection of myocardial viability in chronic coronary artery disease (1995) (0)
541: Cardiac Performance in Patients without Early Native Aortic Valve Opening (2010) (0)
Incidence and Impact of Severe LVAD-related Infections Requiring Surgical Treatment in Obesity Patients on Long-term HeartMate II and HeartWare Support (2018) (0)
Single-Center Experience with Prolonged Circulatory Support (≥5Years) with a Continuous-Flow Left Ventricular Assist Device (2018) (0)
(308) - Comparison of Gastrointentional Bleeding Rates Between Axial Flow (HeartMate II) and Centrifugal (HeartWare) Flow Pumps at a Single Institution (2017) (0)
28-P: Positive Flow Cytometery Crossmatches and Donor-Specific HLA Antibodies May Not Be Contraindications to Heart Transplantation (2010) (0)
Progress in the development of mechanical circulatory support devices (1995) (0)
P037 : LACK OF C1Q REACTIVITY IN POST-LVAD PATIENT SERA (2014) (0)
IMPACT OF PRE-PROCEDURAL PULMONARY ARTERIAL HYPERTENSION AND MITRAL REGURGITATION ON LONG TERM MORTALITY IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES (2020) (0)
IMMUNOSUPPRESSION MAINTENANCE WITH CYCLOPHOSPHAMIDE AND STEROIDS IN PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.: Abstract# 489 Poster Board #‐Session: P129‐II (2000) (0)
High-risk coronary interventions involving percutaneous left ventricular support (2004) (0)
Prior cardiac surgery as a determinant of survival in heart transplant recipients. (1989) (0)
542: Effect of Fibrosis at Implantation on Clinical Outcome in Patients with HeartMate II Ventricular Support (2010) (0)
Abstract 14035: Small Left Ventricle is Risk Factor For Mortality After Axial-flow (Heartmate II) Implantation (2017) (0)
In Memoriam: Denton A. Cooley, MD (1920–2016) (2017) (0)
IMPACT OF TRANSMYOCARDIAL LASER REVASCULARIZATION VERSUS MEDICAL MANAGEMENT IN MYOCARDIAL PERFUSION. (1999) (0)
Post-operative obesity and cachexia are risk factors for post heart transplant morbidity and mortality: a multi-institutional study of post-operative weight change (2003) (0)
Socioeconomic Disparities Do Not Impact Outcomes After Continuous Flow Left Ventricular Assist Device Implantation (2018) (0)
Heart Failure Recovery with Mechanical Circulatory Support (2004) (0)
Left Ventricular Functional Recovery after Long-Term Mechanical Unloading with Left Ventricular Assist Device, the Recent Texas Heart Institute Experience (2007) (0)
Incidence and Impact of Late Right Heart Failure After Continuous-flow Left Ventricular Assist Device Implantation (2018) (0)
Age is not a factor in survival of patients undergoing left ventricular assist device placement as destination therapy: The REMATCH experience (2003) (0)
Relevance of HLA Ab and a donor specific FCXM to rejection and graft survival in cardiac allograft recipients (2004) (0)
Long-term Survival Following Heart Transplantation (2001) (0)
228: Effects of left ventricular assist devices with different flow characteristics on vasopressin levels (2006) (0)
283: Post Transplant Survival Following Support with a Continuous Flow Left Ventricular Assist Device (2009) (0)
Clinical Characteristics and Outcomes of Patients Supported with Left Ventricular Assist Devices: Are Bridge-to-Transplant and Destination Therapy Populations Different? (2006) (0)
Stand in 2003? Mechanical Circulatory Support for Advanced Heart Failure: Where Does It (2010) (0)
Effects of Nesiritide on Pulmonary Hypertension in Heart Transplant Candidates (2004) (0)
Announcement of a New Series: From the Archives of the Texas Heart Institute Journal (2004) (0)
548: Experience with the TandemHeart Percutaneous Ventricular Assist Device in Heart Failure Patients Undergoing Cardiac Surgical Procedures (2009) (0)
Impact of Donor Smoking History on Graft Survival Following Cardiac Transplantation (2018) (0)
Chapter 56 – Circulatory Assist Devices in Heart Failure (2011) (0)
Magnitude of Bleeding and Blood Product Utilization Predict Early Right Ventricular Implantation in LVAD Recipients (2019) (0)
Transmyocardial Laser Revascularization (TMLR) At the Texas Heart Institute (1998) (0)
Outcomes Using HVAD for Long-term Biventricular Support (2018) (0)
Heterotopic Cardiac Transplantation: Time for Another Look? (2018) (0)
SYNCARDIA MEETS CARDIOMEMS: A LOEFFLER'S STORY (2017) (0)
Abstract TP392: Evaluation of the CHADS 2 , CHA 2 DS 2 -VASc, and R 2 CHADS 2 Risk Assessment Scores in Continuous Flow LVADs (2018) (0)
Hyperhomocysteinemia and Oxidative Stress May Predict the Risk of Stroke in Patients Supported by Continuous Flow Left Ventricular Assist Devices (2021) (0)
Low Volume Centers have Inferior Post-Heart Transplant Survival (2018) (0)
Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients. (1988) (0)
407: Clinical Durability and Low Incidence of Pump Replacement of a Continuous-Flow Left Ventricular Assist Device (2009) (0)
The Effect of Concomitant Mitral Valve Procedures for Severe Mitral Valve Regurgitation During Left Ventricular Assist Device Implantation (2018) (0)
Heterotopic heart allograft explanation following native heart recovery. (1989) (0)
QTc interval prolongation predicts mortality in heart transplant recipients (2003) (0)
80: Real-time hepatic venous saturation: Is it a sensitive indicator of hemodynamic compromise? (2007) (0)
247: Transplantation of Donor Specific Antibody Positive, Crossmatch Negative (AHG/FCXM) Cardiac Allograft Recipients (2009) (0)
Valvular Heart Disease: Surgical Treatment (2007) (0)
Surgical Treatment of Coronary Artery Disease (2015) (0)
Statin treatment decreases QTC interval duration and improves survival in heart transplant recipients (2003) (0)
Continuous-Flow Left Ventricular Assist Devices Have Very Low Rates of Mechanical Failure (2019) (0)
Viral genome in the myocardium and outcomes in heart transplant recipients. (2001) (0)
SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1 (2001) (0)
LUNG CANCER AFTER HEART TRANSPLANTATION.: Abstract# 488 Poster Board #‐Session: P128‐II (2000) (0)
QTC interval prolongation predicts mortality in patients with transplant coronary artery disease (2003) (0)
Outcomes in Patients Bridged to Long-term Continuous Flow Left Ventricular Assist Devices Using Short-term Impella Device (2018) (0)
Heterotopic heart transplantation for selected high-risk patients (1991) (0)
Impact of Hepatic Fibrosis on Outcomes in Patients Undergoing Continuous-Flow LVAD Implantation (2018) (0)
Implantation of the Jarvik 2000 Heart (2002) (0)
Natural History of Mild Aortic Insufficiency at the Time of Left Ventricular Assist Device Implantation for Heartmate II and HVAD (2018) (0)
A Historical Perspective on the Development of Mechanical Circulatory Support Devices (2019) (0)
Effect of Aortic Cross-clamping During Left Ventricular Assist Device Implantation: A Single Institutional 13-year Experience Over 500 Implantations (2018) (0)
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. (1991) (0)
(1304) – Readmission within 30 Days After Continuous Flow Ventricular Assist Devices Implantation - Comparative Analysis of HeartMate II and HeartWare Devices (2017) (0)
POSITIVE FLOW CYTOMETRY CROSSMATCHES AND DONOR-SPECIFIC HLA ANTIBODIES MAY NOT BE CONTRAINDICATIONS TO HEART TRANSPLANTATION: 548 (2010) (0)
Transplantation of the heart in a man from Puerto Rico: a case report. (1986) (0)
NITRIC OXIDE AND PROSTAGLANDIN El THERAPY FOR HEART TRANSPLANT CANDIDATES WITH SECONDARY PULMONARY HYPERTENSION.: Abstract# 464 Poster Board #‐Session: P104‐II (2000) (0)
Circulatory Support 1988. Other postoperative complications. (1989) (0)
A new technique for assessing myocardial improvement using pressure-volume loops during mechanical circulatory assistance (2003) (0)
THE RELEVANCE OF HLA ANTIBODY AND A DONOR SPECIFIC FLOW CYTOMETRY CROSSMATCH TO REJECTION AND GRAFT SURVIVAL IN CARDIAC ALLOGRAFT RECIPIENTS (2004) (0)
Successful treatment of 2 patients with B-cell post-transplant lymphoproliferative disorders with rituximab (2000) (0)
Long-term ventricular assist devices in current clinical practice. (2013) (0)
Preemptive antiviral therapy is highly efficient in preventing cytomegalovirus (CMV) disease in CMV-positive heart transplant recipients (2002) (0)
BOLT Score - A New Prognostic Score for Predicting Survival to Transplant Among Patients on LVAD Support (2018) (0)
The impact of ERA and co-morbidity on the incidence of infection after cardiac transplantation: a 10-year multi-institutional study (2002) (0)
IMMUNOSCINTIGRAPHIC DIAGNOSIS OF CARDIAC ALLOGRAFT REJECTION USING IN VIVO IMAGING WITH RADIOLABELED MONOCLONAL ANTIBODIES TO MHC CLASS II ANTIGENS AND TO INTERCELLULAR ADHESIVE MOLECULE ICAM-I (1996) (0)
545: Impact of pretransplant statin treatment on sensitization and crossmatch results of cardiac allograft recipients (2007) (0)
Induction of Hyperthermia Using Implanted Electrodes1 (2006) (0)
Surgical Treatment of Advanced Heart Failure (2015) (0)
Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness. (2023) (0)
Etiology of Continuous-Flow LVAD (CF-LVAD) Infections (2019) (0)
Panel 4 Other postoperative complications (1989) (0)
Lack of C1q Reactivity in Post-LVAD Patient Sera.: Abstract# A132 (2014) (0)
Histopathologic Effects of Transmyocardial Laser Revascularization on Myocardium: Assessment of Channel Patency (2007) (0)
From Crisis Intervention (0)
Heparin induced thrombocytopenia in patients with an axial flow left ventricular assist device (2004) (0)
Is a more aggressive approach to LVAD placement called for in pretransplant patients requiring IABP placement prior to transplantation (1995) (0)
Clinical Outcomes After Ventricular Assist Device Implantation in Six Adult Patients With Complex Congenital Heart Disease (2012) (0)
(687) - Prolonged Circulatory Support (Five Years or Longer) with Left Ventricular Assist Devices for Patients with Advanced Heart Failure (2017) (0)
240: Evaluation of the Seattle Heart Failure Model in 150 LVAD Recipients (2008) (0)
Chances of Prolonged 5- and 10-year Survival after Continuous-Flow LVAD Implantation? (2021) (0)
Effect of 1gM-Positive Crossmatches on Survival in Heart Transplant Recipients (0)
Cardiac transplantation. (1986) (0)
Editorial Commentary: Retrospective Analysis of 286 Patients Requiring Circulatory Support with the Intraaortic Balloon Pump (2005) (0)
Prediction of GIB Using R2 CHA2DS2 VASc Risk Score (2019) (0)
Mechanical Circulatory Assistance: Introduction (2000) (0)
Extra-Corporeal Membrane Oxygenation (ECMO) as a Bridge to A Long-Term, Implantable Left Ventricular Assist Device (2018) (0)
Predictors and Impact of Vasoplegia after Continuous-Flow Left Ventricular Assist Device Implantation (2019) (0)
Open Heart: The Radical Surgeons Who Revolutionized Medicine (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Oscar Howard Frazier?

Oscar Howard Frazier is affiliated with the following schools:

Oscar Howard Frazier's Academic­Influence.com Rankings

Oscar Howard Frazier's Degrees

Why Is Oscar Howard Frazier Influential?

Oscar Howard Frazier's Published Works

Published Works

What Schools Are Affiliated With Oscar Howard Frazier?

Oscar Howard Frazier's AcademicInfluence.com Rankings